ASX:AMT

Stock Analysis Report

Allegra Orthopaedics

Executive Summary

Allegra Orthopaedics Limited designs, sells, and distributes surgical implants in Australia.


Snowflake Analysis

Adequate balance sheet and overvalued.

Share Price & News

How has Allegra Orthopaedics's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: AMT's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-17.9%

AMT

-1.3%

AU Medical Equipment

0.02%

AU Market


1 Year Return

n/a

AMT

45.9%

AU Medical Equipment

14.6%

AU Market

Return vs Industry: Insufficient data to determine how AMT performed against the Australian Medical Equipment industry.

Return vs Market: Insufficient data to determine how AMT performed against the Australian Market.


Shareholder returns

AMTIndustryMarket
7 Day-17.9%-1.3%0.02%
30 Day-42.5%-0.1%0.2%
90 Day-54.0%7.7%5.4%
1 Yearn/a48.0%45.9%19.7%14.6%
3 Year-47.8%-51.1%82.1%74.2%38.7%20.2%
5 Year53.4%43.8%121.2%103.8%50.6%17.1%

Price Volatility Vs. Market

How volatile is Allegra Orthopaedics's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Allegra Orthopaedics undervalued compared to its fair value and its price relative to the market?

2.35x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate AMT's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate AMT's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: AMT is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.

PE vs Market: AMT is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AMT's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AMT is good value based on its PB Ratio (2.4x) compared to the AU Medical Equipment industry average (4.9x).


Next Steps

Future Growth

How is Allegra Orthopaedics forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

16.8%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Allegra Orthopaedics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Allegra Orthopaedics performed over the past 5 years?

7.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AMT is currently unprofitable.

Growing Profit Margin: AMT is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: AMT is unprofitable, but has reduced losses over the past 5 years at a rate of 7.2% per year.

Accelerating Growth: Unable to compare AMT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AMT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.1%).


Return on Equity

High ROE: AMT has a negative Return on Equity (-24.05%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Allegra Orthopaedics's financial position?


Financial Position Analysis

Short Term Liabilities: AMT's short term assets (A$5.5M) exceed its short term liabilities (A$1.9M).

Long Term Liabilities: AMT's short term assets (A$5.5M) exceed its long term liabilities (A$146.9K).


Debt to Equity History and Analysis

Debt Level: AMT is debt free.

Reducing Debt: AMT had no debt 5 years ago.


Balance Sheet

Inventory Level: AMT has a high level of physical assets or inventory.

Debt Coverage by Assets: AMT's debt is covered by short term assets (assets are 1.966355184119E+17x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AMT has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: AMT has less than a year of cash runway if free cash flow continues to reduce at historical rates of -39.7% each year


Next Steps

Dividend

What is Allegra Orthopaedics's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.3%markettop25%5.4%industryaverage1.3%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate AMT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate AMT's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AMT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AMT's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AMT's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.1yrs

Average management tenure


CEO

Jenny Swain 0

3.8yrs

Tenure

AU$332,984

Compensation

Ms. Jenny Swain has been the Chief Executive Officer of Allegra Orthopaedics Limited since May 2, 2016. Ms. Swain served as Director Sales and Marketing of Allegra Orthopaedics Limited and served as its N ...


CEO Compensation Analysis

Compensation vs Market: Jenny's total compensation ($USD220.94K) is about average for companies of similar size in the Australian market ($USD251.50K).

Compensation vs Earnings: Jenny's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Jenny Swain
Chief Executive Officer3.8yrsAU$332.98k0.27% A$29.4k
Justyn Stedwell
Company Secretary3.1yrsno datano data
Chris Calamos
Commercial & Finance Manager3.1yrsAU$128.83kno data

3.1yrs

Average Tenure

Experienced Management: AMT's management team is considered experienced (3.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Anthony Hartnell
Non-Executive Director5.3yrsAU$46.07k0.54% A$58.9k
Peter Kazacos
Non-Executive Chairman4.3yrsAU$63.59k0.24% A$26.2k
Sean St Mulhearn
Non-Executive Director4.3yrsAU$46.07k0.73% A$80.1k
Nicholas Hartnell
Non-Executive Director1.9yrsAU$45.00k1.22% A$133.6k

4.3yrs

Average Tenure

65yo

Average Age

Experienced Board: AMT's board of directors are considered experienced (4.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Allegra Orthopaedics Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Allegra Orthopaedics Limited
  • Ticker: AMT
  • Exchange: ASX
  • Founded: 1994
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: AU$10.951m
  • Shares outstanding: 99.56m
  • Website: https://www.allegraorthopaedics.com

Location

  • Allegra Orthopaedics Limited
  • 18-20 Orion Road
  • Level 8
  • Lane Cove West
  • New South Wales
  • 2066
  • Australia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AMTASX (Australian Securities Exchange)YesOrdinary SharesAUAUDDec 2007

Biography

Allegra Orthopaedics Limited designs, sells, and distributes surgical implants in Australia. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems, knee distal first instruments, and screws, as well as femoral condyle, PF wave, and nanofracture technology products. The company also provides foot and ankle products, such as total ankle replacement systems, toe products, A-curve handles, screws, and staples; surgical screws, sawblades, and kirschner wires; and microfracture handles. In addition, it offers consulting services. The company was formerly known as Advanced Surgical Design & Manufacture Limited and changed its name to Allegra Orthopaedics Limited in November 2014. Allegra Orthopaedics Limited was founded in 1994 and is based in Lane Cove West, Australia. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/02/23 10:39
End of Day Share Price2020/02/19 00:00
Earnings2019/12/31
Annual Earnings2019/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.